name: Grade 5 Central Nervous System Necrosis, CTCAE


name: Grade 5 Cerebrospinal Fluid Leakage, CTCAE


name: Grade 5 Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE


name: Grade 5 Cytokine Release Syndrome, CTCAE


name: Grade 5 Cytomegalovirus Infection Reactivation, CTCAE


name: Grade 5 Depressed Level of Consciousness, CTCAE


name: Grade 5 Ear and Labyrinth Disorders - Other, Specify, CTCAE


name: Grade 5 Encephalomyelitis Infection, CTCAE


name: Grade 5 Endocrine Disorders - Other, Specify, CTCAE


name: Grade 5 Epstein-Barr Virus Infection Reactivation, CTCAE


name: Grade 5 Esophageal Anastomotic Leak, CTCAE


name: Grade 5 Fallopian Tube Anastomotic Leak, CTCAE


name: Grade 5 Fibrosis Deep Connective Tissue, CTCAE


name: Grade 5 Gastrointestinal Anastomotic Leak, CTCAE


name: Grade 5 Gastrointestinal Disorders - Other, Specify, CTCAE


name: Grade 5 Gastrointestinal Stoma Necrosis, CTCAE


name: Grade 5 General Disorders and Administration Site Conditions - Other, Specify, CTCAE


name: Grade 5 Glossopharyngeal Nerve Disorder, CTCAE


name: Grade 5 Hemolytic Uremic Syndrome, CTCAE


name: Grade 5 Hepatobiliary Disorders - Other, Specify, CTCAE


name: Grade 5 Herpes Simplex Reactivation, CTCAE


name: Grade 5 Immune System Disorders - Other, Specify, CTCAE


name: Grade 5 Infusion Related Reaction, CTCAE


name: Grade 5 Infusion Site Extravasation, CTCAE


name: Grade 5 Injury To Superior Vena Cava, CTCAE


name: Grade 5 Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE


name: Grade 5 Intestinal Stoma Obstruction, CTCAE


name: Grade 5 Intestinal Stoma Site Bleeding, CTCAE


name: Grade 5 Intra-Abdominal Hemorrhage, CTCAE


name: Grade 5 Intraoperative Arterial Injury, CTCAE


name: Grade 5 Intraoperative Breast Injury, CTCAE


name: Grade 5 Intraoperative Cardiac Injury, CTCAE


name: Grade 5 Intraoperative Ear Injury, CTCAE


name: Grade 5 Intraoperative Endocrine Injury, CTCAE


name: Grade 5 Intraoperative Gastrointestinal Injury, CTCAE


name: Grade 5 Intraoperative Head and Neck Injury, CTCAE


name: Grade 5 Intraoperative Hemorrhage, CTCAE


name: Grade 5 Intraoperative Hepatobiliary Injury, CTCAE


name: Grade 5 Intraoperative Musculoskeletal Injury, CTCAE


name: Grade 5 Intraoperative Neurological Injury, CTCAE


name: Grade 5 Intraoperative Ocular Injury, CTCAE


name: Grade 5 Intraoperative Renal Injury, CTCAE


name: Grade 5 Intraoperative Reproductive Tract Injury, CTCAE


name: Grade 5 Intraoperative Respiratory Injury, CTCAE


name: Grade 5 Intraoperative Splenic Injury, CTCAE


name: Grade 5 Intraoperative Urinary Injury, CTCAE


name: Grade 5 Intraoperative Venous Injury, CTCAE


name: Grade 5 Investigations - Other, Specify, CTCAE


name: Grade 5 Large Intestinal Anastomotic Leak, CTCAE


name: Grade 5 Laryngopharyngeal Dysesthesia, CTCAE


name: Grade 5 Leukemia Secondary To Oncology Chemotherapy, CTCAE


name: Grade 5 Lower Gastrointestinal Hemorrhage, CTCAE


name: Grade 5 Metabolism and Nutrition Disorders - Other, Specify, CTCAE


name: Grade 5 Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE


name: Grade 5 Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE


name: Grade 5 Nervous System Disorders - Other, Specify, CTCAE


name: Grade 5 Pancreatic Anastomotic Leak, CTCAE


name: Grade 5 Paroxysmal Atrial Tachycardia, CTCAE


name: Grade 5 Peripheral Motor Neuropathy, CTCAE


name: Grade 5 Peripheral Nerve Infection, CTCAE


name: Grade 5 Pharyngeal Anastomotic Leak, CTCAE


name: Grade 5 Postoperative Thoracic Procedure Complication, CTCAE


name: Grade 5 Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE


name: Grade 5 Prolapse of Intestinal Stoma, CTCAE


name: Grade 5 Psychiatric Disorders - Other, Specify, CTCAE


name: Grade 5 Radiation Recall Reaction (Dermatologic), CTCAE


name: Grade 5 Recurrent Laryngeal Nerve Palsy, CTCAE


name: Grade 5 Renal and Urinary Disorders - Other, Specify, CTCAE


name: Grade 5 Reproductive System and Breast Disorders - Other, Specify, CTCAE


name: Grade 5 Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE


name: Grade 5 Retroperitoneal Hemorrhage, CTCAE


name: Grade 5 Reversible Posterior Leukoencephalopathy Syndrome, CTCAE


name: Grade 5 Salivary Duct Inflammation, CTCAE


name: Grade 5 Sinusoidal Obstruction Syndrome, CTCAE


name: Grade 5 Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE


name: Grade 5 Small Intestinal Anastomotic Leak, CTCAE


name: Grade 5 Small Intestinal Mucositis, CTCAE


name: Grade 5 Small Intestinal Obstruction, CTCAE


name: Grade 5 Small Intestinal Perforation, CTCAE


name: Grade 5 Small Intestinal Stenosis, CTCAE


name: Grade 5 Small Intestine Infection, CTCAE


name: Grade 5 Social Circumstances - Other, Specify, CTCAE


name: Grade 5 Soft Tissue Necrosis Upper Limb, CTCAE


name: Grade 5 Spermatic Cord Anastomotic Leak, CTCAE


name: Grade 5 Stenosis of Gastrointestinal Stoma, CTCAE


name: Grade 5 Superficial Soft Tissue Fibrosis, CTCAE


name: Grade 5 Superior Vena Cava Syndrome, CTCAE


name: Grade 5 Surgical and Medical Procedures - Other, Specify, CTCAE


name: Grade 5 Thrombotic Thrombocytopenic Purpura, CTCAE


name: Grade 5 Toxic Epidermal Necrolysis, CTCAE


name: Grade 5 Tracheostomy Site Bleeding, CTCAE


name: Grade 5 Treatment Related Secondary Malignancy, CTCAE


name: Grade 5 Upper Gastrointestinal Hemorrhage, CTCAE


name: Grade 5 Upper Respiratory Infection, CTCAE


name: Grade 5 Ureteric Anastomotic Leak, CTCAE


name: Grade 5 Urethral Anastomotic Leak, CTCAE


name: Grade 5 Urinary Tract Obstruction, CTCAE


name: Grade 5 Vas Deferens Anastomotic Leak, CTCAE


name: Grade 5 Vascular Access Complication, CTCAE


name: Grade 5 Vascular Disorders - Other, Specify, CTCAE


name: Grade 5 Visceral Arterial Ischemia, CTCAE


name: Blasts More Than 5 Percent of Peripheral Blood White Cells


name: Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells


name: Lymphoblasts 20 Percent or More of Peripheral Blood White Cells


name: Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells


name: Blasts 30 Percent or Less of Peripheral Blood White Cells


name: Blasts 5-30 Percent of Bone Marrow Nucleated Cells


name: Blasts 5-25 Percent of Bone Marrow Nucleated Cells


name: Blasts 20-30 Percent of Bone Marrow Nucleated Cells


name: PSA Doubling Time Less than or Equal to 6 Months


name: Since First Time Questionnaire Was Answered Question


name: Minimally Invasive Interval Debulking Surgery


name: Mediastinal Germ Cell Tumor Distant Metastasis TNM Finding


name: Mediastinal Germ Cell Tumor M0 TNM Finding


name: Mediastinal Germ Cell Tumor M1 TNM Finding


name: Mediastinal Germ Cell Tumor Primary Tumor TNM Finding


name: Mediastinal Germ Cell Tumor TX TNM Finding


name: Mediastinal Germ Cell Tumor T0 TNM Finding


name: Mediastinal Germ Cell Tumor T1 TNM Finding


name: Mediastinal Germ Cell Tumor T1a TNM Finding


name: Mediastinal Germ Cell Tumor T1b TNM Finding


name: Mediastinal Germ Cell Tumor T2 TNM Finding


name: Mediastinal Germ Cell Tumor T2a TNM Finding


name: Mediastinal Germ Cell Tumor T2b TNM Finding


name: Mediastinal Germ Cell Tumor T3 TNM Finding


name: Mediastinal Germ Cell Tumor T4 TNM Finding


name: Mediastinal Germ Cell Tumor Regional Lymph Nodes TNM Finding


name: Mediastinal Germ Cell Tumor NX TNM Finding


name: Mediastinal Germ Cell Tumor N0 TNM Finding


name: Mediastinal Germ Cell Tumor N1 TNM Finding


name: Mediastinal Germ Cell Tumor N2 TNM Finding


name: Mediastinal Germ Cell Tumor N3 TNM Finding


name: Mediastinal Malignant Germ Cell Tumor Stage


name: Observed Medical Device Type In Intended Location


name: Supplemental Qualifiers Tabulation Dataset


name: Worst Nausea Past 24 Hours Rating Question


name: Undesirable Sedation Troubles Past 24 Hours Rating Question


name: Undesirable Appetite Increase Past 24 Hours Rating Question


name: Blasts 1 Percent or More of Peripheral Blood White Cells


name: Blasts 6-19 Percent of Bone Marrow Nucleated Cells


name: CDISC Protocol Study Purpose Response Terminology


name: CDISC Protocol Subject Allocation Response Terminology


name: CDISC Protocol Randomization Type Response Terminology


name: Chromogranin-Positive Neoplastic Cells Present


name: Antigen-Presentation Machinery Expression Profile


name: Observed Medical Device Type Not Present In Intended Location Type


name: Associated Persons Laboratory Test Results Domain


name: Associated Persons Medical History Domain


name: Associated Persons Questionnaires Domain


name: Relationship between Associated Persons and Subjects Domain


name: Associated Persons Reproductive System Findings Domain


name: Adverse Events Supplemental Qualifiers Dataset


name: Procedure Agents Supplemental Qualifiers Dataset


name: Biospecimen Events Supplemental Qualifiers Dataset


name: Biospecimen Findings Supplemental Qualifiers Dataset


name: Body Weight Supplemental Qualifiers Dataset


name: Clinical Events Supplemental Qualifiers Dataset


name: Clinical Observations Supplemental Qualifiers Dataset


name: Concomitant and Prior Medications Supplemental Qualifiers Dataset


name: Comments Supplemental Qualifiers Dataset


name: Cardiovascular System Findings Supplemental Qualifiers Dataset


name: Drug Accountability Supplemental Qualifiers Dataset


name: Death Details (human clinical trials) Supplemental Qualifiers Dataset


name: Device Events Supplemental Qualifiers Dataset


name: Device Identifiers Supplemental Qualifiers Dataset


name: Demographics Supplemental Qualifiers Dataset


name: Device Properties Supplemental Qualifiers Dataset


name: Device Subject Relationships Supplemental Qualifiers Dataset


name: Disposition Supplemental Qualifiers Dataset


name: Device Tracking and Disposition Supplemental Qualifiers Dataset


name: Device In-Use Supplemental Qualifiers Dataset


name: Protocol Deviations Supplemental Qualifiers Dataset


name: Device Exposure Supplemental Qualifiers Dataset


name: Exposure as Collected Supplemental Qualifiers Dataset


name: ECG Test Results Supplemental Qualifiers Dataset


name: Exposure Supplemental Qualifiers Dataset


name: Findings About Events or Interventions Supplemental Qualifiers Dataset


name: Fetal Measurements Supplemental Qualifiers Dataset


name: Food and Water Consumption Supplemental Qualifiers Dataset


name: Fetal Pathology Findings Supplemental Qualifiers Dataset


name: Healthcare Encounters Supplemental Qualifiers Dataset


name: Implantation Classification Supplemental Qualifiers Dataset


name: Inclusion/Exclusion Criteria Not Met Supplemental Qualifiers Dataset


name: Immunogenicity Specimen Assessments Supplemental Qualifiers Dataset


name: Laboratory Test Results Supplemental Qualifiers Dataset


name: Macroscopic Findings Supplemental Qualifiers Dataset


name: Microbiology Specimen Supplemental Qualifiers Dataset


name: Medical History Supplemental Qualifiers Dataset


name: Microscopic Findings Supplemental Qualifiers Dataset


name: Musculoskeletal System Findings Supplemental Qualifiers Dataset


name: Meal Data Supplemental Qualifiers Dataset


name: Microbiology Susceptibility Supplemental Qualifiers Dataset


name: Nervous System Findings Supplemental Qualifiers Dataset


name: Ophthalmic Examinations Supplemental Qualifiers Dataset


name: Non-Host Organism Identifiers Supplemental Qualifiers Dataset


name: Organ Measurements Supplemental Qualifiers Dataset


name: Pharmacogenomics/Genetics Biomarker Supplemental Qualifiers Dataset


name: Pharmacokinetics Concentrations Supplemental Qualifiers Dataset


name: Physical Examination Supplemental Qualifiers Dataset


name: Pharmacogenomics/Genetics Findings Supplemental Qualifiers Dataset


name: Pharmacogenomics/Genetics Methods and Supporting Information Supplemental Qualifiers Dataset


name: Palpable Masses Supplemental Qualifiers Dataset


name: Pharmacokinetic Parameters Supplemental Qualifiers Dataset


name: Procedures Supplemental Qualifiers Dataset


name: Questionnaires Supplemental Qualifiers Dataset


name: ECG QT Correction Model Data Supplemental Qualifiers Dataset


name: Respiratory Test Results Supplemental Qualifiers Dataset


name: Reproductive System Findings Supplemental Qualifiers Dataset


name: Disease Response Supplemental Qualifiers Dataset


name: Subject Biomarker Supplemental Qualifiers Dataset


name: Subject Characteristics Supplemental Qualifiers Dataset


name: Subject Elements Supplemental Qualifiers Dataset


name: Subject Stages Supplemental Qualifiers Dataset


name: Subject Disease Milestones Supplemental Qualifiers Dataset


name: Skin Response Supplemental Qualifiers Dataset


name: Subject Status Supplemental Qualifiers Dataset


name: Substance Use Supplemental Qualifiers Dataset


name: Subject Visits Supplemental Qualifiers Dataset


name: Trial Arms Supplemental Qualifiers Dataset


name: Trial Disease Assessments Supplemental Qualifiers Dataset


name: Trial Elements Supplemental Qualifiers Dataset


name: Tumor Findings Supplemental Qualifiers Dataset


name: Trial Inclusion and Exclusion Criteria Supplemental Qualifiers Dataset


name: Trial Disease Milestones Supplemental Qualifiers Dataset


name: Trial Paths Supplemental Qualifiers Dataset


name: Tumor Response Supplemental Qualifiers Dataset


name: Trial Summary Supplemental Qualifiers Dataset


name: Trial Stages Supplemental Qualifiers Dataset


name: Tumor/Lesion Identification Supplemental Qualifiers Dataset


name: Trial Sets Supplemental Qualifiers Dataset


name: Urinary System Findings Supplemental Qualifiers Dataset


name: Vital Signs Supplemental Qualifiers Dataset


name: Whole Body Findings Supplemental Qualifiers Dataset


name: Neutralizing Binding Antidrug Antibody Measurement


name: Neutralizing Cross-Reacting Binding Antidrug Antibody Measurement


name: Cross-Reactive Binding Antidrug Antibody Measurement


name: Arachis hypogaea Antigen IgE Antibody Measurement


name: Triticum aestivum Antigen IgE Antibody Measurement


name: Glycine max Antigen IgE Antibody Measurement


name: Zea mays Antigen IgE Antibody Measurement


name: Cow Milk Protein Antigen IgE Antibody Measurement


name: Egg White Antigen IgE Antibody Measurement


name: White Oak Pollen IgE Antibody Measurement


name: White Elm Pollen IgG Antibody Measurement


name: Boxelder Pollen IgE Antibody Measurement


name: Common Ragweed Pollen IgE Antibody Measurement


name: Cladosporium herbarum IgE Antibody Measurement


name: Penicillium chrysogenum IgE Antibody Measurement


name: Acylcarnitine to Free Carnitine Ratio Measurement


name: Alpha Fetoprotein Adjusted for Body Weight Measurement


name: Apolipoprotein A1 to Apolipoprotein B Ratio Measurement


name: Bone Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement


name: Intestinal Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement


name: Liver Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement


name: Acetylcholine Receptor Modulation Antibody to Acetylcholine Receptor Antibody Ratio Measurement


name: Atypical Neutrophil Cytoplasmic Antibody Measurement


name: Classic Neutrophil Cytoplasmic Antibody Measurement


name: Antithrombin Activity Actual to Control Ratio Measurement


name: Beta-2 Glycoprotein 1 IgA Antibody Measurement


name: Borrelia burgdorferi IgG and IgM Antibody Measurement


name: Calcium Corrected for Total Protein Measurement


name: Cyclic Citrullinated Peptide IgG Antibody Measurement


name: Macromolecular Type 1 Creatine Kinase to Total Creatine Kinase Ratio Measurement


name: Macromolecular Type 2 Creatine Kinase to Total Creatine Kinase Ratio Measurement


name: Cryoglobulin Volume to Serum Volume Ratio Measurement


name: Factor VIII Activity Actual to Control Ratio Measurement


name: Factor XIV Activity Actual to Control Ratio Measurement


name: Granulocytes to Leukocytes Ratio Measurement


name: Hemoglobin A2 Prime to Total Hemoglobin Ratio Measurement


name: Hemoglobin Barts to Total Hemoglobin Ratio Measurement


name: Carboxyhemoglobin to Total Hemoglobin Ratio Measurement


name: Hemoglobin G Coushatta to Total Hemoglobin Ratio Measurement


name: Hemoglobin Lepore to Total Hemoglobin Ratio Measurement


name: Hemoglobin O-Arab to Total Hemoglobin Ratio Measurement


name: Oxyhemoglobin to Total Hemoglobin Ratio Measurement


name: Free Choriogonadotropin Beta Measurement


name: Hemoglobin A1 to Total Hemoglobin Ratio Measurement


name: Hemoglobin D to Total Hemoglobin Ratio Measurement


name: Hemoglobin E to Total Hemoglobin Ratio Measurement


name: Hemoglobin F to Total Hemoglobin Ratio Measurement


name: Methemoglobin to Total Hemoglobin Ratio Measurement


name: IDL Cholesterol and VLDL Cholesterol Subtype 3 Measurement


name: Clefted Lymphocytes to Leukocytes Ratio Measurement


name: Lymphoma Cells to Leukocytes Ratio Measurement


name: Monocytes and Macrophages to Leukocytes Ratio Measurement


name: Nonhematic Cells to Leukocytes Ratio Measurement


name: Type 1 Collagen X-link N-Telopeptides to Creatinine Ratio Measurement


name: Partial Pressure of Carbon Dioxide Adjusted for Body Temperature Measurement


name: Immature Plasma Cells to Total Cells Ratio Measurement


name: Partial Pressure of Oxygen Adjusted for Body Temperature Measurement


name: Phosphatidylglycerol to Lung Surfactant Ratio Measurement


name: Free Protein S Activity Actual to Control Ratio Measurement


name: Reptilase Activity Actual to Control Ratio Measurement


name: Motile Sperm to Total Sperm Ratio Measurement


name: Thrombin Activity Actual to Control Ratio Measurement


name: Free Testosterone to Testosterone Ratio Measurement


name: Free Testosterone and Weakly Bound to Total Testosterone Ratio Measurement


name: Tissue Transglutaminase IgM Antibody Measurement


name: Vitamin D2 and Vitamin D3 and 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 Measurement


name: 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Measurement


name: von Willebrand Factor Activity Actual to Control Ratio Measurement


name: Transthoracic Echocardiography With Contrast


name: Kumar IMWG 2016 Oncology Response Criteria


name: Absolute Change in Longest Diameter From Nadir Product of Perpendicular Diameters Timepoint


name: Absolute Change in Longest Perpendicular from Nadir Product of Perpendicular Diameters Timepoint


name: Planned Pharmacologic Target Common Name


name: Planned Pharmacologic Target Entrez Gene Identifier


name: Planned Pharmacologic Target Entrez Gene Symbol


name: Planned Pharmacologic Target Mode of Action


name: HER2/Neu Expression by Immunohistochemistry 0


name: HER2/Neu Expression by Immunohistochemistry 1+


name: HER2/Neu Expression by Immunohistochemistry 2+


name: HER2/Neu Expression by Immunohistochemistry 3+


name: CDISC Clinical Classification ATLAS Test Name Terminology


name: CDISC Clinical Classification ATLAS Test Code Terminology


name: CDISC Questionnaire FACT-BMT Version 4 Test Name Terminology


name: CDISC Questionnaire FACT-BMT Version 4 Test Code Terminology


name: CDISC Questionnaire FACIT-Dyspnea 10 Item Short Form Test Name Terminology


name: CDISC Questionnaire FACIT-Dyspnea 10 Item Short Form Test Code Terminology


name: CDISC Questionnaire FACIT-Fatigue 13-Item Version 4 Test Name Terminology


name: CDISC Questionnaire FACIT-Fatigue 13-Item Version 4 Test Code Terminology


name: CDISC Questionnaire Peds-FACIT-F Test Name Terminology


name: CDISC Questionnaire Peds-FACIT-F Test Code Terminology


name: CDISC Questionnaire TSCC Test Name Terminology


name: CDISC Questionnaire TSCC Test Code Terminology


name: CDISC Questionnaire TSCYC Test Name Terminology


name: CDISC Questionnaire TSCYC Test Code Terminology


name: FACT-BMT Version 4 Questionnaire Question


name: FACIT-Dyspnea 10 Item Short Form Questionnaire Question


name: Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire


name: Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire


name: Trauma Symptom Checklist for Children Questionnaire


name: Trauma Symptom Checklist for Young Children Questionnaire


name: FACT-BMT Version 4 - I Have a Lack of Energy


name: FACT-BMT Version 4 - Trouble Meeting Needs of Family


name: FACT-BMT Version 4 - Bothered by Treatment Side Effect


name: FACT-BMT Version 4 - I Am Forced to Spend Time in Bed


name: FACT-BMT Version 4 - I Feel Close to My Friends


name: FACT-BMT Version 4 - Get Emotional Support From Family


name: FACT-BMT Version 4 - I Get Support From My Friends


name: FACT-BMT Version 4 - My Family Has Accepted My Illness


name: FACT-BMT Version 4 - Satisfied Communication Illness


name: FACT-BMT Version 4 - I Feel Close to My Partner


name: FACT-BMT Version 4 - I Am Satisfied With My Sex Life


name: FACT-BMT Version 4 - Losing Hope Against Illness


name: FACT-BMT Version 4 - I Worry About Dying


name: FACT-BMT Version 4 - Worry My Condition Will Get Worse


name: FACT-BMT Version 4 - My Work Is Fulfilling


name: FACT-BMT Version 4 - I Am Able to Enjoy Life


name: FACT-BMT Version 4 - I Have Accepted My Illness


name: FACT-BMT Version 4 - Enjoy Things I Usually Do for Fun


name: FACT-BMT Version 4 - Content With Quality of My Life


name: FACT-BMT Version 4 - I Am Concerned About Keeping Job


name: FACT-BMT Version 4 - I Feel Distant From Other People


name: FACT-BMT Version 4 - I Worry Transplant Will Not Work


name: FACT-BMT Version 4 - Side Effect of Treatment Worse


name: FACT-BMT Version 4 - I Have a Good Appetite


name: FACT-BMT Version 4 - I Like the Appearance of My Body


name: FACT-BMT Version 4 - I Am Able to Get Around by Myself


name: FACT-BMT Version 4 - I Am Interested in Sex


name: FACT-BMT Version 4 - Concerns Ability to Have Children


name: FACT-BMT Version 4 - Confidence in My Nurse(s)


name: FACT-BMT Version 4 - I Regret Bone Marrow Transplant


name: FACT-BMT Version 4 - I Can Remember Things


name: FACT-BMT Version 4 - I Am Able to Concentrate


name: FACT-BMT Version 4 - I Have Frequent Colds/Infections


name: FACT-BMT Version 4 - My Eyesight Is Blurry


name: FACT-BMT Version 4 - Bothered by Change in Food Tastes


name: FACT-BMT Version 4 - I Have Been Short of Breath


name: FACT-BMT Version 4 - I Am Bothered by Skin Problems


name: FACT-BMT Version 4 - I Have Trouble With My Bowels


name: FACT-BMT Version 4 - Illness Is Hardship for My Family


name: FACT-BMT Version 4 - Cost of Treatment Is Burden on Me


name: FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Without Help


name: FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps


name: FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs


name: FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals


name: FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes


name: FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed


name: FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs


name: FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs


name: FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile


name: FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile Why Not


name: FACIT-Dyspnea 10 Item Short Form - Part II: Dressing Without Help


name: FACIT-Dyspnea 10 Item Short Form - Part II: Walk 50 Steps


name: FACIT-Dyspnea 10 Item Short Form - Part II: Walk Up 20 Stairs


name: FACIT-Dyspnea 10 Item Short Form - Part II: Preparing Meals


name: FACIT-Dyspnea 10 Item Short Form - Part II: Washing Dishes


name: FACIT-Dyspnea 10 Item Short Form - Part II: Sweeping/Mopping


name: FACIT-Dyspnea 10 Item Short Form - Part II: Making a Bed


name: FACIT-Dyspnea 10 Item Short Form - Part II: Lifting 10-20 Lbs


name: FACIT-Dyspnea 10 Item Short Form - Part II: Carry 10-20 Lbs


name: FACIT-Dyspnea 10 Item Short Form - Part II: Walk for 1/2 Mile


name: FACIT-Fatigue 13-Item Version 4 - I Feel Fatigued


name: FACIT-Fatigue 13-Item Version 4 - I Feel Weak All Over


name: FACIT-Fatigue 13-Item Version 4 - I Feel Listless


name: FACIT-Fatigue 13-Item Version 4 - I Feel Tired


name: FACIT-Fatigue 13-Item Version 4 - Trouble Starting Things


name: FACIT-Fatigue 13-Item Version 4 - Trouble Finishing Things


name: FACIT-Fatigue 13-Item Version 4 - I Have Energy


name: FACIT-Fatigue 13-Item Version 4 - Able to Do My Usual Activities


name: FACIT-Fatigue 13-Item Version 4 - I Need to Sleep During the Day


name: FACIT-Fatigue 13-Item Version 4 - I Am Too Tired to Eat


name: FACIT-Fatigue 13-Item Version 4 - Need Help Doing Usual Activities


name: FACIT-Fatigue 13-Item Version 4 - Frustrated by Being Too Tired


name: FACIT-Fatigue 13-Item Version 4 - Limit Social Activity, I am Tired


name: Peds-FACIT-F - Could Do My Usual Things at Home


name: Peds-FACIT-F - I Needed to Sleep During the Day


name: Peds-FACIT-F - Hard for Me to Play With Friends


name: Peds-FACIT-F - Needed Help Doing Usual Things


name: TSCC - Afraid Something Bad Might Happen


name: TSCC - Scary Ideas Just Pop Into My Head


name: TSCC - Washing Myself Because Feel Dirty


name: TSCC - Can't Stop Thinking Something Bad


name: TSCC - Wishing Bad Things Never Happened


name: TSCYC - Worrying Someone Might Be Sexual


name: TSCYC - Blaming for Things Weren't Fault


name: TSCYC - Drawing Pictures Upsetting Thing


name: TSCYC - Not Noticing What He or She Doing


name: TSCYC - Playing Games Something Bad Past


name: TSCYC - Trouble Remember Upsetting Thing


name: TSCYC - Changing Subject About Bad Thing


name: TSCYC - Seeming to Be Million Miles Away


name: TSCYC - Watching Out for Possible Danger


name: TSCYC - Frightened Something Sexual Seen


name: TSCYC - Not Sleeping for Two or More Days


name: TSCYC - Not Paying Attention in Own World


name: TSCYC - Drawing Pictures About Sex Things


name: TSCYC - Throwing Things at Friends/Family


name: TSCYC - Temporary Blindness or Paralysis


name: TSCYC - Not Going to Bed First Time Asked


name: TSCYC - Fear He or She Killed by Someone


name: TSCYC - Acting as If Didn't Have Feelings


name: TSCYC - Acting Like He or She Was in Trance


name: TSCYC - Upset When Reminded Bad Happened


name: TSCYC - Not Wanting to Eat Certain Foods


name: TSCYC - Yelling at Family, Friends or Teachers


name: TSCYC - Intentionally Hurt Other Children


name: Allogeneic Hematopoietic Stem Cell Transplant Recipient


name: Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire


name: Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System


name: Blasts Under 20,000 in Peripheral Blood White Cells


name: F-18 Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging


name: C-11 Choline Positron Emission Tomography and Magnetic Resonance Imaging


name: Tumor protein p53 gene mutation not detected


name: Prosigna Breast Cancer Prognostic Gene Signature Assay


name: Renal Pelvis and Ureter Cancer TNM Finding v8


name: Satisfaction with How You Look in Mirror Clothed Question


name: Breast Cancer Surgeon Answered all Questions Question


name: Purchased Services, Ancillary Support, Transportation, Shuttle


name: DRRI-2 - D: Assault on Entrenched Positions


name: DRRI-2 - J: Leader Interested What Thought


name: DRRI-2 - M: Problems Get in Touch Family


name: Blasts More than 5 Percent of Bone Marrow Nucleated Cells


name: Blasts Under 30 Percent of Peripheral Blood White Cells


name: Endocrine Disorders - Other, Specify, CTCAE


name: Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE


name: Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE


name: Renal and Urinary Disorders - Other, Specify, CTCAE


name: Grade 1 Intraoperative Hepatobiliary Injury, CTCAE


name: Grade 2 Activated Partial Thromboplastin Time Prolonged, CTCAE


name: Grade 2 Small Intestinal Obstruction, CTCAE


name: Grade 2 Ureteric Anastomotic Leak, CTCAE


name: Grade 3 Cardiac Troponin I Increased, CTCAE


name: Grade 3 General Disorders and Administration Site Conditions - Other, Specify, CTCAE


name: Grade 3 Musculoskeletal Deformity, CTCAE


name: Grade 3 Paroxysmal Atrial Tachycardia, CTCAE


name: Grade 3 Sinusoidal Obstruction Syndrome, CTCAE


name: Grade 4 Hemolytic Uremic Syndrome, CTCAE


name: Grade 4 Laryngopharyngeal Dysesthesia, CTCAE


name: Grade 4 Small Intestinal Mucositis, CTCAE


name: Grade 5 Infections and Infestations - Other, Specify, CTCAE


name: Grade 5 Soft Tissue Necrosis Lower Limb, CTCAE


name: CDISC Protocol Entities Study Design Attribute Terminology


name: Associated Persons Adverse Events Domain


name: Body Weight Gain Supplemental Qualifiers Dataset


name: Trial Visits Supplemental Qualifiers Dataset


name: Protein S Activity Actual to Control Ratio Measurement


name: FACT-BMT Version 4 - Satisfied With How I Am Coping


name: FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping


name: TSCYC - Not Wanting to Be Around Someone


name: Mycosis Fungoides and Sezary Syndrome Distant Metastasis TNM Finding v8


name: Estrogen Receptor Positive by Immunohistochemistry 11-20 Percent


name: Lacrimal Gland Carcinoma Pathologic TNM Finding v8


name: Ocular Adnexal Lymphoma pM1b TNM Finding v8


name: Uterine Corpus Carcinoma and Carcinosarcoma TNM Finding v8


name: Gestational Trophoblastic Neoplasm TNM Finding v8


name: Conjunctival Carcinoma pM1 TNM Finding v8


name: Computer-Based Cognitive Stimulation Intervention


name: Conjunctival Melanoma Pathologic Primary Tumor TNM Finding v8


name: acetylcysteine/mecobalamin/levomefolate calcium 600 mg-2 mg-6 mg ORAL TABLET


name: Omeprazole + SyrSpend SF Alka, 2 mg/mL oral suspension


name: pediatric multivitamin no.12 with sodium fluoride 0.5 mg ORAL TABLET,CHEWABLE


name: diclofenac sodium/menthol 1.5 %-10 % TOPICAL COMBINATION PACKAGE (ML)


name: GLYCERIN 0.5 mg in 1 mL TOPICAL GEL [Glizigen Gel Intimate]


name: OCTINOXATE 50 mg in 1 mL / TITANIUM DIOXIDE 19 mg in 1 mL TOPICAL CREAM [10 Armani Prima Control Glow Moisturizer SBS SPF 35]


name: allantoin 0.0015 g in 1.5 g TOPICAL LIQUID [Step 1 Serum]


name: NIACINAMIDE 0.045 g in 1.5 g / allantoin 0.0015 g in 1.5 g TOPICAL CREAM [Step 3]


name: NIACINAMIDE 0.9 g in 30 g / PANTHENOL 0.03 g in 30 g / Allantoin 0.03 g in 30 g TOPICAL PATCH [Step 2 Bio-cellulose mask]


name: xanthan gum 6 gram ORAL GEL IN PACKET (GRAM)


name: xanthan gum 6 gram ORAL GEL WITH PUMP (ML)


name: Tissue Human Implantation Sheet [DermACELL AWM]


name: Gelatin Sponge;Thrombin, Bovine 5000 IU Multiple Routes Kit


name: ALUMINUM CHLOROHYDRATE 120 mg in 1 mL TOPICAL LOTION [Kiehls Since 1851 Body Fuel Antiperspirant and Deodorant]


name: AVOBENZONE 0.09 g in 4.67 g / OCTINOXATE 0.35 g in 4.67 g TOPICAL STICK [SnugZ SPF 15 Beeswax Lip Balm]


name: OCTISALATE 0.23 g in 4.67 g / OCTOCRYLENE 0.37 g in 4.67 g / AVOBENZONE 0.14 g in 4.67 g TOPICAL STICK [SnugZ SPF 30 Soy Lip Balm]


name: AVOBENZONE 0.9 g in 50 mL / HOMOSALATE 3 g in 50 mL / OCTOCRYLENE 0.93 g in 50 mL TOPICAL CREAM [Sei Bella Advanced Revital R3 Age Defying Creme]


name: Avobenzone 30 mg in 1 mL / HOMOSALATE 88 mg in 1 mL / Octisalate 49 mg in 1 mL / Octocrylene 59 mg in 1 mL TOPICAL LOTION [Kiehls Since 1851 Facial Fuel Daily Energizing Moisture Treatment for Men Broad Spectrum SPF 20 Sunscreen]


name: TITANIUM DIOXIDE 1.245 g in 15 g / OCTINOXATE 1.05 g in 15 g / OCTISALATE 0.45 g in 15 g TOPICAL CREAM [Celebeau Star Secret Cushion 01 Pink Star]


name: TITANIUM DIOXIDE 1.65 g in 33 mL / OCTINOXATE 2.475 g in 33 mL / ZINC OXIDE 0.3267 g in 33 mL TOPICAL LOTION [Sei Bella CC Brightening Creme Fair]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [Oh My Bod SPF50 Antioxidant Infused Dry Touch Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL TOPICAL CREAM [Resting Beach Face SPF30 Anti-Pollution Sunscreen Serum]


name: OCTINOXATE 5.5 g in 100 g / OXYBENZONE 1 g in 100 g / HOMOSALATE 5 g in 100 g / AVOBENZONE 2.9 g in 100 g TOPICAL CREAM


name: OCTINOXATE 7.5 g in 100 g / OXYBENZONE 4 g in 100 g / HOMOSALATE 3 g in 100 g / AVOBENZONE 2.9 g in 100 g TOPICAL CREAM


name: BAG,AEROSOL DRAINAGE WITH Y CONNECTOR AIRLIFE #55001561


name: CATHETER FOLEY 2-WAY 14FR 10ML M#DYND11754


name: CATHETER FOLEY 2-WAY 16FR 10ML M#DYND11756


name: CATHETER FOLEY 2-WAY 20FR 10ML M#DYND11760


name: TRACH STOMA PROTECTOR,FILTER FRAME CARDINAL #22038


name: CATHETER,FOLEY SILICONE DOVER 26FR 5ML COVIDIEN #605262IC


name: CATHETER,INTERMITTENT VAPRO PLUS 16FR H #71164


name: DRESSING,SORBACELL FOAM 4IN X 4IN #84344


name: TRACH TUBE,SZ 8 BIVONA FOME-CUF SMITHS #850180


name: EXTERNAL URINE MANAGEMENT SYSTEM,FEMALE SAGE #5400


name: INSULIN SYRINGE 0.3ML 31G 6MM (1/2 UNIT MARKINGS)


name: BANDAGE KIT,COMPRESSION COMPRI2 LITE 9 3/4IN X 12 1/2IN


name: Accu-Chek Aviva+ Mtr Kit 59634 Blood-Glucose


name: Accu-Chek Guide Meter Blood-Glucose Meter


name: Beige Original Cotton Tape Cotton 20 / Strip


name: Black Original Cotton Tape Cotton 20 count /


name: Clever Choice Holding Chamber Device Large


name: Clever Choice Holding Chamber Device Medium


name: Clever Choice Holding Chamber Device Small


name: Comfort EZ Pen Needles Miscellaneous 32G X 4


name: KT Flex Reinforced Adhesive Strips 8 Count


name: KT TAPE - ELASTIC SPORT TAPE Beige Cotton


name: KT TAPE - ELASTIC SPORT TAPE Black Cotton


name: KT TAPE - ELASTIC SPORT TAPE Blue Cotton


name: KT TAPE - ELASTIC SPORT TAPE Gentle Cotton Ta


name: KT TAPE - ELASTIC SPORT TAPE Pink Cotton


name: Pharmacist Choice Alcohol External Pad 70 %


name: Pink Original Cotton Tape Cotton 20/ Strip 10


name: Purple Original Cotton Tape 20/ Strip 10" Pre


name: Red Original Cotton Tape Cotton 20/ Strip 10"


name: Stealth Beige Pro Synthetic 20 Count Tape


name: Winter Green Pro Synthetic 20 Count Tape


name: lue Original Cotton Tape Cotton 20 / Strip 10


name: enu Complete Nutrition Shake (Creamy Chocolate)


name: enu Complete Nutrition Shake (Vanilla Cream)


name: ENROFLOXACIN 4.95 kg in 5 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Octocrylene 0.47 g in 9.5 g / Homosalate 0.47 g in 9.5 g / Octisalate 0.42 g in 9.5 g / Avobenzone 0.38 g in 9.5 g / Octinoxate 0.33 g in 9.5 g TOPICAL STICK [TAKO PORE SEBUM SUN]


name: OCTISALATE 2 g in 100 mL / TITANIUM DIOXIDE 5.5 g in 100 mL TOPICAL CREAM [ELF Oil free flawless Finish SPF 15 Sunscreen Foundation Buff]


name: TITANIUM DIOXIDE 4.45 g in 100 mL / OCTISALATE 3 g in 100 mL / OCTINOXATE 4 g in 100 mL TOPICAL CREAM [ELF Flawless Finish Foundation Oil Free SPF 15 Sunscreen Light Ivory]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [CHUDA]


name: AVOBENZONE 0.000714 mg in 28 mL / OCTISALATE 0.00198 mg in 28 mL / OCTOCRYLENE 0.0018 mg in 28 mL TOPICAL LOTION [SnugZ SPF 30 Broad Spectrum Sunscreen]


name: AVOBENZONE 3 g in 100 g / OCTINOXATE 7.5 g in 100 g TOPICAL CREAM [Advanced Formula Lip Balm SPF 25]


name: AVOBENZONE 0.09 g in 4.67 g / OCTINOXATE 0.35 g in 4.67 g TOPICAL STICK [SnugZ SPF 15 Flavored Beeswax Lip Balm]


name: AVOBENZONE 2.5 g in 100 g / DIMETHICONE 17.5 g in 100 g / OCTINOXATE 6 g in 100 g / OCTOCRYLENE 2 g in 100 g TOPICAL STICK [OKeeffes Lip Repair]


name: TITANIUM DIOXIDE 3.65 g in 50 mL / ZINC OXIDE 3.49 g in 50 mL TOPICAL CREAM [DR FROG INTENSIVE CALMING SUN BLOCK]


name: STREPTOMYCIN SULFATE 24.75 kg in 25 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TRILOSTANE .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TRILOSTANE 24.75 kg in 25 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Dexamethasone Sodium Phosphate;Isopropyl Alcohol;Povidone Iodine 10 MG/1 ML; 70%; 10% Multiple Routes Kit [TopiDex]


name: GLYCERIN 0.94 g in 4.7 g / NIACINAMIDE 0.094 g in 4.7 g / ADENOSINE 0.00188 g in 4.7 g TOPICAL PATCH [CELDERMA Ninetalks Hydrogel Eye Patch Box]


name: 5-hydroxy-L-tryptophan (oxitriptan) MISCELL POWDER (GRAM)


name: silica gel, amorphous synthetic micronized 100 % MISCELL POWDER (GRAM)


name: TRILOSTANE 4.95 kg in 5 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: multicellular organismal biosynthetic process


name: negative regulation of homeostatic process


name: positive regulation of homeostatic process


name: induction by symbiont in host of tumor, nodule, or growth


name: induction by symbiont in host of tumor, nodule, or growth containing transformed cells


name: induction of tumor, nodule, or growth containing transformed cells in other organism during symbiotic interaction


name: positive regulation of growth plate cartilage chondrocyte proliferation


name: negative regulation of growth plate cartilage chondrocyte proliferation


name: regulation of formation of radial glial scaffolds


name: regulation of Bergmann fiber biosynthesis


name: negative regulation of premature acrosome loss


name: regulation of entry into reproductive diapause


name: negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process


name: Extracellular Polymeric Substance Matrix


name: negative regulation of energy homeostasis


name: positive regulation of energy homeostasis


name: regulation of postsynaptic specialization assembly


name: regulation of postsynaptic density assembly


name: postsynaptic modulation of chemical synaptic transmission


name: regulation of presynapse organization and biogenesis


name: positive regulation of aggregation involved in sorocarp development


name: regulation of nematode male tail tip morphogenesis


name: regulation of nematode pharynx morphogenesis


name: positive regulation of small intestinal transit


name: negative regulation of small intestinal transit


name: pyloric sphincter smooth muscle contraction


name: positive regulation of stomach fundus smooth muscle contraction


name: negative regulation of stomach fundus smooth muscle contraction


name: negative regulation of pyloric antrum smooth muscle contraction


name: negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process


name: regulation of trans-synaptic signaling by endocannabinoid, modulating synaptic transmission


name: regulation of postsynaptic neurotransmitter receptor diffusion trapping


name: Diclofenac Sodium;Cream Base NA Multiple Routes Kit


name: syringe with needle, insulin, safety, 0.3 mL 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle, insulin, safety, 0.5 mL 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle, insulin, safety, 1 mL 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: infant formula with iron/docosahexaenoic acid/arachidonic ac 2.1 gram-5.4 gram-10.9 gram/100 kcal ORAL LIQUID (ML)


name: CETIRIZINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: CETIRIZINE HYDROCHLORIDE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TITANIUM DIOXIDE 250 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Mineral Daily Tone Correcting Primer Broad Spectrum SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 90 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [SkinCeuticals Physical Matte UV Defense Broad Spectrum SPF 50 Sunscreen]


name: Nutritional Supplement Oral Liquid [Ultrient 1.5]


name: Bifidobacterium animalis / Lactobacillus acidophilus


name: ZINC OXIDE 1.5 g in 30 mL / TITANIUM DIOXIDE 1.5 g in 30 mL TOPICAL LOTION [Sei Bella Tinted BB Moisturizing Creme Light to Medium 160 N]


name: AVOBENZONE 28.5 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTINOXATE 70 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OCTOCRYLENE 90 mg in 1 mL TOPICAL CREAM [Pur Confort SPF 15]


name: Zinc Oxide 175 mg in 1 mL TOPICAL CREAM [Chem-Free Active Defense SPF 30]


name: HYDROQUINONE 0.04 mg in 1 mL TOPICAL EMULSION [ZO Skin Health Pigment Control plus Brightening Creme Hydroquinone plus Vitamin C]


name: Flexichamber Anti-Static Valved Collapsible H


name: TechLITE Insulin Syringe 31 g X 6 mm 0.3 mL


name: TechLITE Insulin Syringe 31 g X 6 mm 0.5 mL


name: TechLITE Insulin Syringe 31 g X 6 mm 1 mL


name: Xeroform Occlusize Petrolatum Gauze Patch 2x2


name: ESTRADIOL BENZOATE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TADALAFIL 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TRIPELENNAMINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 18 g in 57 g TOPICAL GEL [Helmm Antiperspirant Deodorant Hudson]


name: HYDROQUINONE 0.04 g in 1 mL TOPICAL EMULSION [ZO Skin Health Pigment Control Plus Blending Creme Hydroquinone]


name: hypochlorous acid/sodium hypochlorite/sod chlorid/elec.water 0.012 %-0.002 %-0.046 %-99.94 % TOPICAL SPRAY, NON-AEROSOL (ML)


name: Assure ID 1/2 mL 29G 1/2 inch Insulin Safety Syringe


name: Assure ID 1mL 29G 1/2 inch Insulin Safety Syringe


name: Ensure MAX Protein Nutrition Shake (Cafe Mocha)


name: Ensure MAX Protein Nutrition Shake (Milk Chocolate)


name: Glucocard Expression Blood Glucose Test Strip


name: Glucocard Shine Blood Glucose Test Strip


name: Nutricia SOD Anamix Early Years Powder for Suspension


name: Walgreens Automatic Arm Blood Pressure Monitor System


name: Walgreens Manual Inflate Blood Pressure Kit


name: Walgreens True Focus Self Monitoring Blood Glucose Test Strip


name: Walgreens True Metrix AIR Blood Glucose Meter Kit


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL LOTION [Solar Protection Fluid Broad Spectrum SPF 50]


name: AMLODIPINE BESYLATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TIOPRONIN 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ALUMINUM CHLOROHYDRATE 20 g in 100 mL TOPICAL LIQUID [Odorono Antiperspirant and Deodorant Roll-on Original]


name: Homosalate 100 mg in 1 mL / MERADIMATE 50 mg in 1 mL / Octinoxate 50 mg in 1 mL / Octocrylene 20 mg in 1 mL / Zinc oxide 63 mg in 1 mL TOPICAL LOTION [CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen]


name: CATHERIZATION SET,INTERMITTENT 16FR RUSCH #RLA-162-3C


name: CATHETER FOLEY 2-WAY 10FR 3ML PECO #PF5810


name: CATHETER,INTERMITTENT 12FR COLOPLAST #28412


name: CATHETER,INTERMITTENT 18FR COLOPLAST #28418


name: CATHETER,INTERMITTENT COUDE 16FR PECO #PU816C


name: CATHETER,INTERMITTENT,MAGIC3 16FR ROCHESTER #50616


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,MEN LARGE


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,MEN X-LARGE


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,WOMEN MEDIUM


name: DEPEND UNDERWEAR,MAXIMUM ABSORB,WOMEN SMALL


name: SUCTION CANISTER 725ML DEVILBISS #DV7310P603


name: syringe w-needle,insulin 0.5 mL (half unit mark)


name: Niacinamide 2.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL CREAM [MORINGA PURIFY WATER]


name: silicone adhesive 1.4" X 6" TOPICAL STRIP


name: parenteral electrolytes combination no.26


name: parenteral electrolytes combination no.27


name: ZINC OXIDE 190 mg in 1 mL TOPICAL CREAM [LBri Pure n Natural SPF 30]


name: COMBINATION PACK,DROPS AND VISCOUS DROPS


name: diluent for ixabepilone (castor oil/alcohol) 8 mL INTRAVEN VIAL (ML)


name: diluent for ixabepilone (castor oil/alcohol)


name: diluent for ixabepilone (castor oil/alcohol) 23.5 mL INTRAVEN VIAL (ML)


name: nutritional supplement,special formula,lactose free,iron/soy 0.04 gram-1 kcal/mL ORAL LIQUID (ML)


name: OCTINOXATE 7.5 g in 100 mL / OCTOCRYLENE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 2.5 g in 100 mL TOPICAL SPRAY [Kinesys]


name: BUTYLSCOPOLAMINE BROMIDE 49.5 g in 50 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TYLOSIN 19.8 kg in 20 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate


name: ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride


name: {1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution) } Pack


name: SILDENAFIL CITRATE 24.75 g in 25 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: SILDENAFIL CITRATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: SILDENAFIL CITRATE 9.9 g in 10 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: SILDENAFIL CITRATE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: magnesium glycinate 10 % MISCELL POWDER (GRAM)


name: xanthan gum 96 gram ORAL GEL IN PACKET (GRAM)


name: Silicone Topical application Patch, Extended Release [Coatamax Patch]


name: Capsaicin/Menthol/Methyl Salicylate;Diclofenac Sodium 0.025%-6%-25%; 50 MG Multiple Routes Kit


name: Capsaicin/Menthol/Methyl Salicylate;Ibuprofen 0.025%-6%-25%; 800 MG Multiple Routes Kit


name: Capsaicin/Menthol/Methyl Salicylate;Nabumetone 0.025%-6%-25%; 500 MG Multiple Routes Kit


name: Ceftriaxone Sodium;Lidocaine/Prilocaine 2 GM; 2.5%-2.5% Multiple Routes Kit


name: Ceftriaxone Sodium;Lidocaine/Prilocaine 2 GM; 2.5%-2.5% Multiple Routes Kit [Ceftri-IM Injection]


name: Ceftriaxone Sodium;Sodium Chloride 2 GM; 0.9% Multiple Routes Kit [Ceftrisol Plus]


name: Heparin Sodium;Lidocaine/Prilocaine;Sodium Chloride 100 U/1 ML; 2.5%-2.5%; 0.9% Multiple Routes Kit [HepMed IV Pack]


name: AMOXICILLIN .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: LUFENURON 22.77 kg in 23 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: LUFENURON 24.75 kg in 25 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: PREGABALIN 4.95 kg in 5 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: OCTINOXATE 1.54 g in 22 g / OCTISALATE 0.99 g in 22 g / OCTOCRYLENE 0.44 g in 22 g TOPICAL STICK [OrgaPlus Ultra Pure Sun EX 22g]


name: ALOE VERA LEAF 0.01 g in 100 mL TOPICAL LIQUID [Splendid Betta Complete Water Conditioner]


name: ALOE VERA LEAF 0.01 g in 100 mL TOPICAL LIQUID [API Betta Water Conditioner]


name: Adalimumab;Adalimumab 40 MG/0.4 ML; 80 MG/0.8 ML Subcutaneous Solution


name: Assesses risk factors for perioperative pressure injury


name: Assesses cultural and value components related to pain


name: Assesses the presence of implantable orthopedic hardware


name: Assesses appropriate use of patient safety devices


name: Assesses appropriate use of clinical alarm systems


name: Evaluates for physical injury to skin and tissue


name: Evaluates involvement in healthcare decision making


name: Establishes peripheral intravenous (IV) access


name: Manages the length of operative or invasive procedure by planning care


name: RNFA collaborates with healthcare providers to perform certain delegated medical functions


name: Administers prescribed intravenous solutions


name: Administers prescribed medications based on laboratory or point-of-care results


name: Administers prescribed medications based on pain assessment


name: Administers prescribed prophylactic antiemetic medications based on assessment


name: Applies monitoring equipment to manage body temperature


name: Performs venipuncture for blood specimens


name: Manages for signs and symptoms of infection


name: Implements deep breathing and coughing exercises


name: Collaborates with the appropriate health care providers to initiate new treatments or change existing treatments


name: Provides information related to physiological and diagnostic study result variances


name: Collaborates with patient or designated support person in discharge planning


name: Manages supplies and equipment within safe parameters


name: Collaborates, develops, and implements an individualized plan of care


name: Implements security measures for patient records, belongings, and valuables


name: Provides information related to identified patient risks impacting care


name: Free from injury related to a perioperative chemical source


name: Free from injury related to a perioperative radiation source


name: Free from injury related to transfer/transport within the perioperative environment


name: Wound is consistent with the stages of wound healing or improved from baseline levels


name: Free from injury related to perioperative equipment, medical supplies, or instrumentation


name: Free from injury related to a perioperative electrical source


name: Free from injury related to perioperative positioning


name: At increased risk for perioperative equipment injury


name: At increased risk of postoperative nausea and vomiting


name: At increased risk for transfer/transport injury


name: At increased risk of impaired musculoskeletal function


name: At increased risk for perioperative chemical injury


name: At increased risk for retained surgical item


name: At increased risk for perioperative team communication harm


name: At risk for perioperative specimen management harm


name: Assesses cultural, spiritual and individual beliefs, values, and preferences concerning care


name: Focal deposition of amyloid in dermal papillae


name: Amorphous eosinophilic material in papillary dermis


name: Duffy null phenotype confers complete resistance to infection by the malarial parasite Plasmodium vivax (see 613665.0002)


name: BMP2, IVS1AS, 2-BP DEL/2-BP INS, -7-2AG/CC, 5-PRIME UTR


name: Entrapment/dysfunction of cranial nerves (I, II, V, VII, and VIII)


name: Osteosclerosis of calvaria and skull base


name: Reduced sensation in trigeminal distribution


name: Diffuse loss of peripheral visual acuity


name: Multifocal well-differentiated beta-cell neuroendocrine tumors


name: Low serum glucose with inappropriately high insulin levels


name: Black spots in center of endothelial cells


name: Normal development in patients who are treated and survive infancy


name: Glomeruloid vascular proliferation in the retina Central visual impairment


name: Agenesis of the rostrum of corpus callosum


name: Subnormal response of testosterone to human chorionic gonadotropin stimulation


name: Low urinary androgen metabolite excretion


name: Increased urinary pregnenetriol excretion


name: Increased ratio of 17-alpha-hydroxyprogesterone to androgen metabolites


name: Maturation arrest at primary spermatocyte (pachytene stage)


name: Hypoplasia of the upper crus of the antihelix


name: Low urinary 5-hydroxyindoleacetic acid (5-HIAA)


name: Hemolytic anemia, acute (drug-induced or following ingestion of fava beans)


name: Heinz bodies seen on methyl violet staining


name: High forehead with ridging of metopic and sagittal sutures


name: Increased bone thickness at the sagittal suture line


name: CYP2C8, ARG139LYS AND LYS399ARG (dbSNP rs11572080 AND dbSNP rs10509681)


name: PEX6, 4-BP DEL, +442TAAA, 3-PRIME UTR (dbSNP rs144286892)


name: PEX6, ARG860TRP (dbSNP rs61753230) AND 4-BP DEL, +442TAAA, 3-PRIME UTR (dbSNP rs144286892)


name: Well-demarcated depigmented area of macular atrophy


name: Reduced photopic responses seen on electroretinography (ERG)


name: Diminished scotopic responses seen on ERG


name: Moderate flattening of corneal curvature


name: Diffuse atrophy of retinal pigment epithelium


name: Strands of uveal tissue covering trabecular meshwork


name: Combined defect in N- and mucin-type O-glycosylation


name: Transiently reduced levels of coagulation factors


name: Very high low-density lipoprotein (LDL) cholesterol (>400 mg/dL)


name: GPNMB, 2-BP DEL, 719TG (dbSNP rs747723062)


name: GPNMB, 4-BP DEL, 877TGTT (dbSNP rs773435101)


name: Hypertrophic myocytes with enlarged hyperchromatic nuclei


name: Increased interstitial fibrous connective tissue


name: Hearing loss, prelingual sensorineural (severe to profound)


name: Normal hearing despite being homozygous for a deafness-causing mutation in the GAB1 gene (604439.0001)


name: Abnormal isoelectric focusing of serum transferrin, consistent with CDG type I


name: Hypoglycosylation of serum glycoproteins


name: Hypoglycosylation of serum transferrin, consistent with CDG type I


name: Defective lipid-linked oligosaccharide (LLO) assembly


name: FARSB, 1-BP DEL/2-BP INS, 1486C/AA (dbSNP SCV000676381)


name: Seizures, nocturnal, usually occur in clusters


name: UFM1, 3-BP DEL, -273TCA, PROMOTER (dbSNP rs747359907)


name: Erythrocyte sedimentation rate may be increased


name: Premature fusion of parietotemporal sutures


name: Notching of multiple vertebral bodies, superior and inferior


name: Sparse scalp hair (parietal area may be particularly affected)


name: Hypertrichosis (including face, neck, trunk, and limbs)


name: Pneumothorax due to bronchopleural fistula


name: Syndactyly (2-3-4 on right and 2-3 on left)


name: Palmar keratoderma in linear pattern along flexor aspect of fingers


name: Diffuse background palmoplantar thickening


name: Perinuclear condensation of keratin filaments


name: Peripheral keratin network sparse to absent in some areas


name: Herpes simplex encephalitis, acute infection


name: Positive HSV-1 antibodies in serum and CSF


name: Impaired production of anti-viral interferon in response to stimulation


name: Decreased levels of histidine-rich glycoprotein (HRG)


name: Left superior vena cava to coronary sinus


name: Increased levels of shortened plasma and urinary dolichols


name: Absent ossification of middle and distal phalanges


name: Dysmorphic facial features, nonspecific, variable


name: Impaired interferon response to HSV infection


name: Increased susceptibility to herpes simplex encephalitis


name: Nonspecific white matter abnormalities on brain imaging


name: Bone-spicule and clumping pigmentation in retinal periphery


name: Fibroblasts show a reduction of and disorganization in collagen XII in the extracellular matrix


name: Increased susceptibility to herpes encephalitis (HSV-1)


name: Muscle biopsy shows marked fiber size variability


name: Wedging of vertebral bodies at thoracolumbar junction


name: Fine white scale on upper limbs and trunk


name: Reduced or absent sperm with progressive motility


name: Night blindness in infancy or early childhood


name: Hypopigmentation of midperipheral retinal pigment epithelium (RPE)


name: Markedly reduced or undetectable rod responses seen on electroretinography (ERG)


name: Subnormal to undetectable cone responses seen on ERG


name: Loss of inner- and/or outer-segment photoreceptor cells seen on optical coherence tomography


name: Tapering fingers Persistent fetal fingerpads


name: Decreased width of the cerebellar vermis


name: 'Salt and pepper' stippling of calvarium


name: Subluxation of first carpometacarpal joints


name: Underdevelopment of the cerebral parenchyma


name: Bone marrow analysis may show defective myeloid differentiation


name: Neuroglial heterotopias in temporal horn roof


name: Upper lip attached to maxilla by mucosal fold


name: Vertebral wedging, with round anterior ends


name: Reduced mineralization of upper extremities


name: Bilateral partial syndactyly of second and third toes


name: Atrophy of retinal pigment epithelium in the macula


name: Decreased activities of mitochondrial complexes I, III, and IV, variable in different tissues


name: Decreased activities of mitochondrial respiratory complexes I, III, and IV, variable in different tissues


name: Accessory ossification center at base of second metacarpal


name: Fusion of middle and distal phalanges in multiple toes


name: Severely reduced to extinguished responses on electroretinography


name: Sensorimotor neuropathy (upper and lower limbs affected)


name: Preserved compound muscle action potentials (CMAP)


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19


name: Abnormal T2-weighted signals in the caudate


name: Patients have specific susceptibility to HSV-1 and HSV-2 infection, but not to other viruses, bacteria, or fungal agents


name: Selective absence of red cell precursors and progenitors seen on bone marrow biopsy


name: Electrolyte abnormalities due to renal disease


name: Iron accumulation in deep brain regions and in the globus pallidi


name: Iron accumulation in the basal ganglia, globus pallidi, and substantia nigra


name: Amyloid deposits enriched in hyperpigmented lesions


name: Elongated ridges surrounding hyperpigmented lesions


name: Infiltration of immune cells around hyperpigmented lesions


name: Significant accumulation of CD68+ macrophages adjacent to and under amyloid


name: Increased numbers of Langerhans cells in hyperpigmented epidermis


name: Reduced numbers of melanocytes in hypo- and depigmented macules


name: Pigment incontinence in the papillary dermis


name: Fibrillar aggregates near epidermal-dermal junction of hyperpigmented lesions


name: Fibrillar aggregates in borders of hypo- and depigmented lesions


name: 3.5 to 5 Hz polyspike wave discharges seen on EEG


name: Flat vascular malformation in area of lower spine


name: Multifocal spike wave discharges seen on EEG


name: Increased excretion of Krebs cycle intermediates


name: Variably decreased activities of mitochondrial respiratory complexes I, III, and IV in different tissues


name: Signal abnormalities in the thalami, brainstem, and spinal cord


name: Some patients may have normal early development


name: T2-weighted lesions in the basal ganglia


name: Decreased activities of mitochondrial respiratory enzymes, variable


name: Increased follicle-stimulating hormone (FSH) levels


name: Increased luteinizing hormone (LH) levels


name: Nystagmus (horizontal, vertical, rotary)


name: Near-complete absence of progressive motility


name: Severe disorganization of the 9+2 axonemal structure


name: LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7


name: Absent ossification nucleus of proximal femoral epiphysis


name: Slowed background activity with multifocal epileptiform activity seen on EEG


name: Transiently increased serum creatine kinase


name: Iron deposition in the globus pallidus seen on MRI


name: Skin syndactyly of the second and third toes


name: Oocyte maturation arrest at metaphase II


name: Inability to form pronuclei after fertilization


name: Remodeling of long bones of lower extremities


name: Ragged appearance on longitudinal section


name: Hearing loss, sensorineural, symmetric bilateral


name: Serum analysis shows complete loss of total core fucosylated N-glycans


name: T2-weighted hypointensities in the basal ganglia


name: Hearing loss, congenital bilateral, severe to profound Rudimentary lateral semicircular canal


name: Cystic appearance of central bony island


name: MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS


name: ARTERIOVENOUS MALFORMATION OF THE BRAIN, SOMATIC


name: FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2, SUSCEPTIBILITY TO


name: Low amplitude seen on focal macular electroretinography


name: Intermediate nerve conduction velocities (range 30 to 45 m/s)


name: Joint dislocation, recurrent (e.g., shoulder, patella)


name: Large polygonal brown scales and lower limbs


name: Irregular disrupted collagen fibrils ('collagen flowers')


name: Sleep-related paroxysmal epileptic arousals


name: Widening of keratinocyte intracellular spaces in spinous layer


name: Senior Tabs Multivitamin/Multimineral Tablet


name: Infant and Toddler Multivitamin With Iron Drops


name: Clever Choice Comfort EZ 33G 5/32 inch Insulin Pen Needle


name: PERACETIC ACID 8.0 g in 4000 mL TOPICAL LIQUID [Peraflu D]


name: ZINC OXIDE 4.5 g in 50 mL / OCTISALATE 2 g in 50 mL / TITANIUM DIOXIDE 1 g in 50 mL / OCTINOXATE 3 g in 50 mL TOPICAL CREAM [Perfect Shield Rejuve Sunscreen 100]


name: {10 (avatrombopag 20 MG Oral Tablet) } Pack


name: {10 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 40 MG Daily Dose Carton]


name: {15 (avatrombopag 20 MG Oral Tablet) } Pack


name: {15 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 60 MG Daily Dose Carton]


name: AVOBENZONE 1032 mg in 50 mL / HOMOSALATE 2580 mg in 50 mL / OCTINOXATE 3818 mg in 50 mL / OCTOCRYLENE 1548 mg in 50 mL / OXYBENZONE 774 mg in 50 mL TOPICAL CREAM [SHISEIDO BENEFIANCE WRINKLE SMOOTHING DAY]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 80 mg in 1 g / OCTOCRYLENE 55 mg in 1 g / OCTISALATE 20 mg in 1 g TOPICAL LIPSTICK [SPF15]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL STICK [SPF30 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [SPF30 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL SPRAY [SPF30 Sunscreen]


name: OCTINOXATE 48 mg in 2.2 mL / TITANIUM DIOXIDE 65 mg in 2.2 mL TOPICAL CREAM [CLE DE PEAU BEAUTE RADIANT CORRECTOR FOR EYES ALMOND]


name: OCTINOXATE 50 mg in 1 mL / OCTISALATE 30 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [NO BS Moisturizer SPF20]


name: TITANIUM DIOXIDE 60 mg in 1 L / ZINC OXIDE 60 mg in 1 L TOPICAL CREAM [CoralSafe Broad Spectrum SPF30]


name: DRESSING,ALGICELL CALCIUM ALGINATE AG 2IN X 2IN


name: BANDAGE KIT,COMPRESSION COFLEX TLC ZINC STANDARD


name: BANDAGE KIT,COMPRESSION COFLEX TLC ZINC LITE


name: CATHERIZATION SET,FOLEY 18FR 30ML BARD #800318


name: FEEDING SET,ENTERAL PUMP ENFIT MEDLINE#ENFIT70550


name: DIALYSATE,NXSTAGE PUREFLOW #RFP-454 SOLN


name: DRESSING,RESTORE,FOAM W/SILICONE 5IN X 6.2IN


name: DRESSING,CUTIMED SORBACT HYDROACTIVE B 5.5IN X 5.5IN #7993302


name: HEAT & MOISTURE EXCHANGER,BLOM-SINGER HME BE1055EF


name: AVOBENZONE 14 mg in 1 g / OCTINOXATE 14 mg in 1 g / OCTOCRYLENE 7 mg in 1 g TOPICAL CREAM [Daily Defence Shield SPF 30]


name: SILICON DIOXIDE 15.0 g in 100 g / ALCLOXA 0.16 g in 100 g TOPICAL PASTE, DENTIFRICE [Finefra Tooth]


name: Dexcom G6 Sensor 3 pack blood-glucose sensor


name: TRILOSTANE 9.9 kg in 10 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: AMANTADINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: INSULIN SYRINGE 0.3ML 30G 12MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.3ML 30G 8MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.3ML 31G 8MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 29G 12MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 30G 12MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 30G 8MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 31G 6MM (1/2 UNIT MARKINGS)


name: INSULIN SYRINGE 0.5ML 31G 8MM (1/2 UNIT MARKINGS)


name: SET,INFUSION AUTOSOFT XC TANDEM #1001680


name: STATLOCK NASOGASTRIC STABILIZATION DEVICE #NG0120


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND50144


name: TRACHEAL SUCTION SET 14FR HALYARD #22701356


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM185


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM190


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM810


name: Medical Food Oral Powder for Suspension [Glytactin Build 20/20]


name: POLYMYXIN B SULFATE 1 g in 1 g NOT APPLICABLE POWDER


name: Pedialyte AdvancedCare Plus, oral powder for reconstitution


name: multivitamin with minerals combination no.59


name: multivitamin with minerals combination no.60


name: multivitamin with minerals combination no.61


name: multivitamin with minerals combination no.62


name: multivitamin with minerals combination no.63


name: parenteral electrolytes combination no.28


name: colostomy bag, non-sterile 2 1/2"-3" (12") MISCELL EACH


name: nutritional therapy for PKU no.64 6 gram-48 kcal/100 mL ORAL LIQUID (ML)


name: syringe with needle,insulin 0.3 mL (half unit mark) 30 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin 0.5 mL (half unit mark) 30 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin 0.5 mL (half unit mark) 31 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: xanthan gum 48 gram ORAL GEL IN PACKET (GRAM)


name: BENZALKONIUM CHLORIDE 0.12 g in 100 g TOPICAL DRESSING [ANTIBACTERIAL BANDAGES]


name: panthenol / salicylic acid / zinc pyrithione


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Daily Correct CC Cream Broad Sunscreen SPF 35 Light/Medium]


name: OCTINOXATE 3.5 g in 50 g / ZINC OXIDE 2.3 g in 50 g / OCTISALATE 2.25 g in 50 g / TITANIUM DIOXIDE 0.5 g in 50 g TOPICAL CREAM [WIKLAR UV COVER SHIELD]


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Daily Correct CC Cream Broad Spectrum SPF 35 Light]


name: TITANIUM DIOXIDE 3.2 g in 100 mL / ZINC OXIDE 10.3 g in 100 mL TOPICAL LOTION [Kashmere Anti-aging Sunscreen Moisturizer Broad Spectrum SPF 30]


name: {100 (acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet) / 24 (acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet) } Pack


name: {100 (acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin]) / 24 (acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet [Excedrin PM Triple Action]) } Pack [Excedrin PM Triple Action Caplets and Excedrin Extra Strength Pain Reliever]


name: Chlorpheniramine Maleate/Dextromethorphan Hydrobromide;Dextromethorphan Hydrobromide/Guaifenesin 2 MG/10 ML-15 MG/10 ML; 5 MG/5 ML-100 MG/5 ML Oral Solution


name: IDOXURIDINE 9.9 g in 10 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: LANTHANUM CARBONATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: MEBENDAZOLE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [CC Cream Broad Spectrum Sunscreen SPF 35 Fair to Light]


name: OCTINOXATE 2 mg in 1 mL TOPICAL CREAM [Camouflage Concealer Cream]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Hailey 1.5/30 21 Day]


name: Resident assessment protocol 16--Pressure injuries - triggered


name: Resident assessment protocol 16--Pressure injuries - proceed with care


name: Hepatitis E virus Ab.IgM:PrThr:Pt:Ser/Plas:Ord:IA


name: Peer Rejection Survey version 2.0 - parent report - fixed length form - ages 3-12:-:Pt:^Patient:-:NIH Toolbox


name: Peer Rejection Survey version 2.0 - parent report - fixed length form - ages 3-12


name: Mobility - discharge goal during 3D assessment period


name: Positive Peer Interaction Survey version 2.0 - parent report - fixed length form - ages 3-12:-:Pt:^Patient:-:NIH Toolbox


name: Positive Peer Interaction Survey version 2.0 - parent report - fixed length form - ages 3-12


name: Social Withdrawal Survey version 2.0 - parent report - fixed length form - ages 3-12:-:Pt:^Patient:-:NIH Toolbox


name: Social Withdrawal Survey version 2.0 - parent report - fixed length form - ages 3-12


name: Positive Affect Survey version 2.0 - parent report - CAT item bank - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Positive Affect Survey version 2.0 - parent report - CAT item bank - ages 3-7


name: Sadness Survey version 2.0 - parent report - fixed length form - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Sadness Survey version 2.0 - parent report - fixed length form - ages 3-7


name: Fear-Separation Anxiety Survey version 2.0 - parent report - fixed length form - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Fear-Separation Anxiety Survey version 2.0 - parent report - fixed length form - ages 3-7


name: Fear-Over Anxious Survey version 2.0 - parent report - fixed length form - ages 3-7:-:Pt:^Patient:-:NIH Toolbox


name: Fear-Over Anxious Survey version 2.0 - parent report - fixed length form - ages 3-7


name: Self-Efficacy Survey version 2.0 - CAT item bank - ages 8-12:-:Pt:^Patient:-:NIH Toolbox


name: Self-Efficacy Survey version 2.0 - CAT item bank - ages 8-12


name: General Life Satisfaction Survey version 2.0 - CAT item bank - ages 13-17:-:Pt:^Patient:-:NIH Toolbox


name: General Life Satisfaction Survey version 2.0 - CAT item bank - ages 13-17


name: Positive Affect Survey version 2.0 - fixed length form - ages 8-12:-:Pt:^Patient:-:NIH Toolbox


name: Positive Affect Survey version 2.0 - fixed length form - ages 8-12


name: Sadness Survey version 2.0 - fixed length form - ages 8-17:-:Pt:^Patient:-:NIH Toolbox


name: Sadness Survey version 2.0 - fixed length form - ages 8-17


name: Sadness Survey - CAT item bank - age 18+:-:Pt:^Patient:-:NIH Toolbox


name: Sadness Survey - CAT item bank - age 18+


name: Fear Survey version 2.0 - fixed length form - ages 8-17:-:Pt:^Patient:-:NIH Toolbox


name: Fear Survey version 2.0 - fixed length form - ages 8-17


name: Meaning and Purpose Survey - CAT item bank - age 18+:-:Pt:^Patient:-:NIH Toolbox


name: Meaning and Purpose Survey - CAT item bank - age 18+


name: Current number of unhealed pressure injuries at each stage - follow-up or discharge


name: Porcine circovirus type 2 ORF2 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Senecavirus A VP1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: MDS v3.0 - RAI v1.15.1 - Medications - NOD, NP, SOD, SP


name: MDS v3.0 - RAI v1.15.1 - Medications - NSD, ND, SSD, SD


name: Restraints and alarms:-:RptPeriod:^Patient:-:CMS Assessment


name: Other alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Other alarm used during assessment period


name: How much time did you usually spend on one of those D doing vigorous physical activities as part of your work during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing vigorous physical activities as part of your work during the last 7D


name: During the last 7D, on how many D did you do moderate physical activities like carrying light loads as part of your work, not including walking, for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate physical activities like carrying light loads as part of your work, not including walking, for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities as part of your work during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities as part of your work during the last 7D


name: Hydrogen/Expired gas^20M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Multisection^W contrast IV && Multisection for pulmonary embolus^W contrast IV:Find:Pt:Chest && Chest>Pulmonary arteries:Doc:CT && CT.angio


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.right:Doc:CT


name: Guidance for percutaneous biopsy:Find:Pt:Chest>Lung.left:Doc:CT


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.left:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Brain && Head>Head vessels:Doc:CT.perfusion && CT.angio


name: Multisection^W contrast IV:Find:Pt:Head && Head>Head vessels & Neck>Neck vessels:Doc:CT && CT.angio


name: Adenovirus Ag:PrThr:Pt:Respiratory system specimen.lower:Ord:IA


name: Human coronavirus HKU1 RNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Respiratory system specimen.lower:Ord:Probe.amp.tar


name: Herpes simplex virus:Prid:Pt:Respiratory system specimen.lower:Nom:Organism specific culture


name: Human coronavirus 229E RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Human coronavirus 229E RNA:PrThr:Pt:Respiratory system specimen.lower:Ord:Probe.amp.tar


name: Degree of difficulty experienced due to your knee while getting on or off toilet in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while getting on or off toilet in the last W


name: Degree of difficulty experienced due to your knee while sitting in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while sitting in the last W


name: Degree of difficulty experienced due to your knee while getting in or out of bath in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while getting in or out of bath in the last W


name: Degree of difficulty experienced due to your knee while lying in bed (turning over, maintaining hip position) in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while lying in bed (turning over, maintaining hip position) in the last W


name: Degree of difficulty experienced due to your knee while taking off socks or stockings in the last W:Find:1W:^Patient:Ord:KOOS


name: Degree of difficulty experienced due to your knee while taking off socks or stockings in the last W


name: Provider who performed cardiopulmonary resuscitation:Type:Pt:^Patient:Nom


name: Provider who performed cardiopulmonary resuscitation


name: Coagulation factor IX activity actual/Normal:RelCCnc:Pt:PPP:Qn:Chromo


name: Glial nuclear type 1 Ab:ACnc:Pt:Ser:Qn:Line blot


name: Babesia microti Ab.IgG & IgM panel:-:-:Ser:-:IF


name: Amount of knee pain experienced at night while in bed in the last W:Find:1W:^Patient:Ord:KOOS


name: Amount of knee pain experienced at night while in bed in the last W


name: Amount of knee pain experienced while walking on flat surface in the last W:Find:1W:^Patient:Ord:KOOS


name: Amount of knee pain experienced while walking on flat surface in the last W


name: Amount of knee pain experienced while bending knee fully in the last W:Find:1W:^Patient:Ord:KOOS


name: Amount of knee pain experienced while bending knee fully in the last W


name: How often do you experience knee pain:Find:Pt:^Patient:Ord:KOOS


name: How many times have you had chest pain, chest tightness or angina on average over the past 4W:Find:4W:^Patient:Ord:SAQ


name: How many times have you had chest pain, chest tightness or angina on average over the past 4W


name: Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W:Find:4W:^Patient:Ord:SAQ


name: Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W


name: Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W:Find:4W:^Patient:Ord:SAQ


name: Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W


name: Seattle Angina Questionnaire - 7 items:-:Pt:^Patient:-:SAQ


name: Burkholderia sp:Prid:Pt:Respiratory system specimen.lower:Nom:Organism specific culture


name: Bordetella sp:Prid:Pt:Nph:Nom:Organism specific culture


name: Consultation note:Find:Pt:Adult day care center:Doc:Community health care


name: Discharge summary note:Find:Pt:Adult day care center:Doc:Community health care


name: Note:Find:Pt:Adult day care center:Doc:Community health care


name: Note:Find:Pt:Adult day care center:Doc:Community health care.nurse


name: Microbiology CNAMTS panel:-:Pt:Synv fld:-


name: Connective tissue autoimmune Ab panel:-:Pt:Ser:-


name: Fatty acid omega-3 & omega-6 panel:-:Pt:Ser/Plas:-


name: Guidance for radioembolization for tumor^W Yttrium-90 IA:Find:Pt:Abdomen>Hepatic artery:Doc:{Imaging modality}


name: Guidance for repair of aneurysm:Find:Pt:Abdomen>Aorta.abdominal:Doc:{Imaging modality}


name: Guidance for repair of aneurysm:Find:Pt:Chest>Aorta.thoracic:Doc:{Imaging modality}


name: Guidance for repair of endoleak:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance for venous sampling:Find:Pt:Abdomen>Adrenal vein:Doc:{Imaging modality}


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.15.1


name: MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA (NO & SO) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed tracking (NT & ST) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home part A PPS discharge (NPE) item set


name: MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set


name: MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set


name: MDS v3.0 - RAI v1.15.1 - Medications:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Medications received:-:RptPeriod:^Patient:-:CMS Assessment


name: Number of D opioid received in last 7D or since admission &or reentry if less than 7D:Num:7D:^Patient:Qn:CMS Assessment


name: Number of D opioid received in last 7D or since admission &or reentry if less than 7D


name: MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set


name: Glomerular filtration rate:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (CKD-EPI)/1.73 sq M among black population


name: Glomerular filtration rate:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (CKD-EPI)/1.73 sq M among non black population


name: Antipsychotic medication review:-:RptPeriod:^Patient:-:CMS Assessment


name: Antipsychotic medications since admission or entry or reentry or the prior OBRA assessment, whichever is more recent:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Antipsychotic medications since admission or entry or reentry or the prior OBRA assessment, whichever is more recent


name: Gradual dose reduction (GDR) attempted:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Date of last attempted gradual dose reduction:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date of last attempted gradual dose reduction


name: Physician documented GDR as clinically contraindicated:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Physician documented GDR as clinically contraindicated


name: Date physician documented GDR as clinically contraindicated:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Date physician documented GDR as clinically contraindicated


name: Bed alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Chair alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Chair alarm used during assessment period


name: Floor mat alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Floor mat alarm used during assessment period


name: Motion sensor alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Motion sensor alarm used during assessment period


name: Wander or elopement alarm used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Wander or elopement alarm used during assessment period


name: Multisection for perfusion^WO & W contrast IV && Multisection^W contrast IV:Find:Pt:Head>Brain && Head>Head vessels & Neck>Neck vessels:Doc:CT.perfusion && CT.angio


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Spinal cord:Doc:CT


name: Guidance for percutaneous aspiration of fluid:Find:Pt:Chest:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Pulmonary veins:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis+Lower extremity.bilateral:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Neck && Head>Head vessels & Neck>Neck vessels:Doc:CT && CT.angio


name: Guidance for stereotactic localization:Find:Pt:XXX:Doc:CT


name: MDS v3.0 - RAI v1.17.2 - Restraints and alarms - NP, ND, SP, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 2.0


name: Mobility - admission performance during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: Mobility - admission performance during 3D assessment period


name: Mobility - discharge performance during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: Mobility - discharge performance during 3D assessment period


name: IRF-PAI v3.0 - Skin conditions - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v3.0 - Skin conditions - discharge


name: Memory &or recall ability during 3D assessment period:Find:3D:^Patient:Nom:CMS Assessment


name: Memory &or recall ability during 3D assessment period


name: Blood pressure with exercise & post exercise panel:-:Pt:Arterial system:Qn


name: Blood pressure with exercise & post exercise panel


name: Transfer summary note:Find:Pt:Long term care facility:Doc:Nurse


name: History and physical note:Find:Pt:{Setting}:Doc:Polytrauma


name: Medical equipment or product note:Find:Pt:{Setting}:Doc:Audiology


name: Actinobacillus pleuropneumoniae Ab.IgG/Positive control:RelRto:Pt:Saliva:Qn:IA


name: Outcome and assessment information set (OASIS) form - version D, D1 - Transfer to inpatient facility - patient discharged or not discharged:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Transfer to inpatient facility - patient discharged or not discharged


name: Outcome and assessment information set (OASIS) form - version D, D1 - Resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Resumption of care


name: Outcome and assessment information set (OASIS) form - version D - Follow-up - recertification or other follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D - Follow-up - recertification or other follow-up


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency - death at home:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency - death at home


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency


name: Outcome and assessment information set (OASIS) form - version D:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D


name: Outcome and assessment information set (OASIS) form - version D, D1 - Start of care:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D, D1 - Start of care


name: Chemotherapy infusion start & stop date and time panel:-:Pt:^Patient:-


name: Chemotherapy infusion start & stop date and time panel


name: International Physical Activity Questionnaire self-administered long form:-:Pt:^Patient:-:IPAQ


name: International Physical Activity Questionnaire self-administered long form


name: Job-related physical activity panel:-:Pt:^Patient:-:IPAQ


name: Do you currently have a job or do any unpaid work outside your home:Find:Pt:^Patient:Ord:IPAQ


name: Do you currently have a job or do any unpaid work outside your home


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work for at least 10M at a time


name: During the last 7D, on how many D did you walk for at least 10M at a time as a part of your work, not counting any walking you did to travel to or from work:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you walk for at least 10M at a time as a part of your work, not counting any walking you did to travel to or from work


name: How much time did you usually spend on one of those D walking as part of your work during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D walking as part of your work during the last 7D


name: Transportation physical activity panel:-:Pt:^Patient:-:IPAQ


name: During the last 7D, on how many D did you travel in a motor vehicle like a train, bus, car, or tram:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you travel in a motor vehicle like a train, bus, car, or tram


name: How much time did you usually spend on one of those D traveling in a train, bus, car, tram, or other kind of motor vehicle during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D traveling in a train, bus, car, tram, or other kind of motor vehicle during the last 7D


name: During the last 7D, on how many D did you bicycle for at least 10M at a time to go from place to place:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you bicycle for at least 10M at a time to go from place to place


name: How much time did you usually spend on one of those D to bicycle from place to place during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D to bicycle from place to place during the last 7D


name: During the last 7D, on how many D did you walk for at least 10M at a time to go from place to place:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you walk for at least 10M at a time to go from place to place


name: How much time did you usually spend on one of those D walking from place to place during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D walking from place to place during the last 7D


name: Housework, house maintenance, and caring for family panel:-:Pt:^Patient:-:IPAQ


name: Housework, house maintenance, and caring for family panel


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10M at a time


name: How much time did you usually spend on one of those D doing vigorous physical activities in the garden or yard during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing vigorous physical activities in the garden or yard during the last 7D


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities in the garden or yard during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities in the garden or yard during the last 7D


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities inside your home during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities inside your home during the last 7D


name: Recreation, sport, and leisure-time physical activity panel:-:Pt:^Patient:-:IPAQ


name: Recreation, sport, and leisure-time physical activity panel


name: Not counting any walking you have already mentioned, during the last 7D, on how many D did you walk for at least 10M at a time in your leisure time:NRat:7D:^Patient:Qn:IPAQ


name: Not counting any walking you have already mentioned, during the last 7D, on how many D did you walk for at least 10M at a time in your leisure time


name: How much time did you usually spend on one of those D walking in your leisure time during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D walking in your leisure time during the last 7D


name: During the last 7D, on how many D did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10M at a time


name: How much time did you usually spend on one of those D doing vigorous physical activities in your leisure time during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing vigorous physical activities in your leisure time during the last 7D


name: During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time


name: How much time did you usually spend on one of those D doing moderate physical activities in your leisure time during the last 7D:NRat:7D:^Patient:Qn:IPAQ


name: How much time did you usually spend on one of those D doing moderate physical activities in your leisure time during the last 7D


name: Time spent sitting panel:-:Pt:^Patient:-:IPAQ


name: During the last 7D, how much time did you usually spend sitting on a weekend D:NRat:7D:^Patient:Qn:IPAQ


name: During the last 7D, how much time did you usually spend sitting on a weekend D


name: International Physical Activity Questionnaire telephone short form:-:Pt:^Patient:-:IPAQ


name: International Physical Activity Questionnaire telephone short form


name: Vigorous physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Walking physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.work domain:ARat:7D:^Patient:Qn:IPAQ


name: Cycle physical activity.active transportation domain:ARat:7D:^Patient:Qn:IPAQ


name: Cycle physical activity.active transportation domain


name: Walking physical activity.active transportation domain:ARat:7D:^Patient:Qn:IPAQ


name: Walking physical activity.active transportation domain


name: Total physical activity.active transportation domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.active transportation domain


name: Vigorous physical activity.yard work:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.yard work:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.inside chores:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.inside chores


name: Total physical activity.domestic and garden domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.domestic and garden domain


name: Walking physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Walking physical activity.leisure-time domain


name: Vigorous physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Vigorous physical activity.leisure-time domain


name: Moderate physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Moderate physical activity.leisure-time domain


name: Total physical activity.leisure-time domain:ARat:7D:^Patient:Qn:IPAQ


name: Total physical activity.leisure-time domain


name: International Physical Activity Questionnaire telephone long form:-:Pt:^Patient:-:IPAQ


name: International Physical Activity Questionnaire telephone long form


name: Patient counseling information:-:-:^FDA package insert:Nar


name: How supplied & storage & handling section:-:-:^FDA package insert:Nar


name: How supplied & storage & handling section


name: Cardiopulmonary resuscitation start time:ClockTime:Pt:^Patient:Qn


name: Cardiopulmonary resuscitation start time


name: Hydrogen/Expired gas^10M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^10M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^20M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^40M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^40M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^50M post dose fructose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^50M post dose lactose PO:VFr:Pt:Exhl gas:Qn


name: Babesia divergens+MO-1 strain 18S rRNA gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Babesia duncani 18S rRNA gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Babesia microti 18S rRNA gene:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA:PrThr:Pt:Ser/Plas/Bld^Donor:Ord:Probe.amp.tar


name: California encephalitis virus Ab.IgG & IgM panel:-:Pt:Ser:-:IF


name: California encephalitis virus Ab.IgG & IgM panel


name: California encephalitis virus Ab.IgG+IgM:Imp:Pt:Ser:Ord:IF


name: Herpes simplex virus 1 Ab.IgM:PrThr:Pt:CSF:Ord:IF


name: Mumps virus Ab.IgG & IgM panel:-:Pt:CSF:-:IF


name: Serotonin release 1.0 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Serotonin release 50 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Serotonin release 50 IU/mL heparin.low molecular weight


name: Babesia microti & divergens+MO-1 strain & duncani 18S rRNA gene panel:-:Pt:Bld:-:Non-probe.amp.tar


name: Babesia microti & divergens+MO-1 strain & duncani 18S rRNA gene panel


name: OASIS E - Skin Conditions - SOC, ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Integumentary status - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Integumentary status - discharge from agency


name: Types and sources of assistance - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: Types and sources of assistance - start of care or resumption of care


name: Deprecated Care management - start of care or resumption of care [CMS Assessment]


name: Care management - start of care or resumption of care


name: Care management - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: Types and sources of assistance - discarge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: Types and sources of assistance - discarge from agency


name: How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4W:Find:4W:^Patient:Ord:SAQ


name: How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4W


name: Quality of life score:Score:Pt:^Patient:Qn:SAQ


name: If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this:Find:Pt:^Patient:Ord:SAQ


name: If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this


name: How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W:Find:4W:^Patient:Ord:SAQ


name: How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W


name: Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W:Find:4W:^Patient:Ord:SAQ


name: Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W


name: Functional abilities and goals - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: Functional abilities and goals - admission


name: Functional abilities and goals - discharge:-:3D:^Patient:-:CMS Assessment


name: Functional abilities and goals - discharge


name: OASIS D - Functional abilities and goals - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Functional abilities and goals - follow-up


name: OASIS D - Self-care - follow-up performance:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Self-care - follow-up performance


name: OASIS D - Mobility - follow-up performance:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Mobility - follow-up performance


name: OASIS D - Patient history and diagnoses - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Patient history and diagnoses - start of care or resumption of care


name: OASIS E - Diagnoses and symptom control:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Primary diagnosis:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Other diagnoses:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Patient history and diagnoses - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Patient history and diagnoses - follow-up


name: OASIS D - Sensory status - start of care or resumption of care or follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D - Sensory status - start of care or resumption of care or follow-up


name: OASIS D - Integumentary status - start of care or resumption of care


name: OASIS E - Current number of unhealed pressure injuries at each stage - SOC, ROC, FU:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Current number of unhealed pressure injuries at each stage - SOC, ROC, FU


name: OASIS D - Respiratory status - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment